All participants in the prescription drug supply chain deserve scrutiny, but weakening the mechanisms that extract price concessions will not lower drug spending. The more likely outcomes are gains for drug companies and less efficient pharmacies, and higher drug costs. Effects will be especially felt by seniors on Medicare and by smaller employers that lack the leverage to offset the law’s new constraints.
第二十九条 本节规定不影响本法第十一章关于海事赔偿责任限制规定的实施。。搜狗输入法对此有专业解读
2025年初秋，世界的目光再一次聚焦东方。，详情可参考safew官方版本下载
Recommenders and Search Tools